Super-Mega-Optimus Prime

New Post Public Reply Private Reply Replies (1) Message Board
joey68
Super-Mega-Optimus Prime DD
5nFnlaI.png

Earlier today, I put on my DD helmet, DD work pants, and threw my trusty DD pickaxe onto my shoulder in preparation for some more DD digging. Well, after several hours of DD blood, DD sweat, and DD tears, I cleaned the dust from my eyes and found a plethora of information regarding todays PR about SpectraScience acquiring assets of Oncoscope.

As of right now, I have 31 tabs open; all referencing different aspects of the acquisition. Where to start, where to start?

Let's start with the title of the PR:

SpectraScience Acquires Assets of Oncoscope
http://www.marketwired.com/press-release/spec...099356.htm

Every single website I found which included this PR had the same title, "SpectraScience Acquires Assets of Oncoscope". Nothing too dramatic there. But then I got to thinking, "there has to be more to the story than that". So using my DD pickaxe, I wondered if there would be something about Oncoscope with regards to private capital.

So, going to the ole' trusty www.pehub.com website, sure enough I stumbled upon something which had a slightly different, yet very important difference:

Side note: PE HUB has origins back to the 60s and is a great resource.

So, the title of the PR on pehub.com says:
Quote:
SpectraScience buys assets of VC-backed Oncoscope

https://www.pehub.com/2016/02/spectrascience-...oncoscope/

When I read that I started to get excited because I knew that term VC-backed would open recently undiscovered doors.

Click the link above and youll read the following:

Quote:
SpectraScience Inc, a medical device company, acquired the assets of Oncoscope Inc, a Durham, North Carolina-based developer of a proprietary optical imaging system. Oncoscope has received funding from Applied Ventures, IDEA Fund Partners and others, according to earlier press releases.


Wait a minute.. what does that say? Applied Ventures funded Oncoscope? It was at this point that I knew I was going to be stuck at the computer for hours because Applied Ventures is part of a mega-mega..MEGA company, and anything related to them has got to be good!

Side note : If you're wondering what 'IDEA Fund Partners' is, click the link below.
http://ideafundpartners.com/oncoscope/

Back on topic..
Right now, your interest might have peeked slightly over what the heck Applied Ventures is and what it has to do with Oncoscope.

Ok, lets get down to work.
You see, information about Applied Ventures can be read in the link below:
http://www.appliedmaterials.com/company/applied-ventures

This is where it gets interesting. Although Applied Ventures sounds interesting, the really interesting thing is that they are the venture capital arm of Applied Materials .

Let me explain:
Applied Materials, Inc., is on NASDAQ: AMAT. They are worth BILLIONS, yes, BILLIONS of dollars ($9.07 billion in 2014). They are a global leader in nanomanufacturing technology among countless other technologies.

Why should you and I care about this? Simply put, Oncoscope was funded by Applied Ventures . Applied Ventures is run by Applied Materials . Applied Materials, worth BILLIONS of dollars, is not going to fund a company unless their technology shows promise. In other words, Applied Materials was interested enough in Oncoscopes tech that they funded them.

Let's start to put the pieces together:

Go here
http://www.appliedmaterials.com/company/appli.../portfolio
Scroll down until you see Oncoscope.
Quote:
Oncoscope has developed an innovative optical screening platform that uses scattered light to identify cells with enlarged nuclei — the primary early marker for cancer. This proven technology will allow physicians to accurately and instantly identify dysplastic or pre–cancerous tissue for biopsy. This optical guide to biopsy system has been shown to increase the effectiveness of physical biopsies used to detect esophageal cancer, the deadliest and fastest-growing cancer today.


Did you notice this quote is on the Portfolio page of Applied Materials ?

Makes you wonder..now that Spectra Science acquired their assets.. will Applied Materials fund Spectra Science? Maybe, maybe not. I'd say probably not, but who knows. That depends on the type of acquisition. Time will tell.

Note: The link above will be very good DD for one of you fellow DD'ers to keep an eye on to see if Applied Materials removes Oncoscope from their portfolio and/or replaces it with Spectra Science.

Now we begin to uncover hidden DD. Be sure your DD hat is on snugly.. Here we go..
The big elephant in the room right now is, "how much did Spectra Science have to pay for Oncoscope?"

Yikes! Hopefully they didnt pay too much! I mean, if Oncoscope is good enough to get the attention of a billion dollar company, Spectra Science must have paid a trillion dollars!! Right? Actually... no.

And this is where it starts to get real good for us serious investors.

Apparently, the men and women at SCIE did their homework and acquired the assets of Oncoscope for a steal . How do I know this? Prepare yourself..

I know this because Oncoscope filed/ is filing for bankruptcy Apr 10, 2015; only 10 months ago.

Now the DD turns technical. Pull out your DD protective goggles; you're about to get faceslapped with DD.

Here we go..
Go to this link
https://business-bankruptcies.com/cases/oncoscope-inc

Notice it says (see image below)
JIWDBv0.png
And it looks like, at least from what we can see, that this bankruptcy is still ongoing, which is nothing out of the ordinary.
Apr 14, 2015 #5 Order Appointing Trustee. (Admin.) (Entered: 04/14/2015)

Now then, fellow DD'ers, the question is not 'why' Oncoscope filed for Chapter 7. We may never know the 'why'. In fact, there are millions of reasons why a company goes bankrupt, which include Market Conditions, Financing, and Poor Decision Making .

Although it is way too early to tell, it's possible Oncoscope made poor financial decisions. I couldnt find any lawsuits against them, so it appears they didnt get sued, and they have a working technology backed by Applied Materials, so in my opinion, it was poor financial decisions. Time will tell.

Read this..
Quote:
Chapter 7: Liquidation Under the Bankruptcy Code. The chapter of the Bankruptcy Code providing for "liquidation," ( i.e., the sale of a debtor's nonexempt property and the distribution of the proceeds to creditors.).


And this..

Quote:
A chapter 7 bankruptcy case does not involve the filing of a plan of repayment as in chapter 13. Instead, the bankruptcy trustee gathers and sells the debtor's nonexempt assets and uses the proceeds of such assets to pay holders of claims (creditors) in accordance with the provisions of the Bankruptcy Code. Part of the debtor's property may be subject to liens and mortgages that pledge the property to other creditors. In addition, the Bankruptcy Code will allow the debtor to keep certain "exempt" property; but a trustee will liquidate the debtor's remaining assets. Accordingly, potential debtors should realize that the filing of a petition under chapter 7 may result in the loss of property.

http://www.uscourts.gov/FederalCourts/Bankrup...pter7.aspx

We know for a fact , according to the website, that Oncoscope filed for Chapter 7. You may have heard of Chapter 11 and are wondering if they're the same. Nope.

Read the link below:
http://www.investopedia.com/ask/answers/190.asp

Quote:
Chapter 7 bankruptcy is sometimes also called liquidation bankruptcy. Firms experiencing this form of bankruptcy are past the stage of reorganization and must sell off any un-exempt assets to pay creditors.


Quote:
Chapter 11 bankruptcy can also be called rehabilitation bankruptcy. It's much more involved than chapter 7 as it allows the firm the opportunity to reorganize its debt


What this tells us is that Oncoscope has assets and is selling them to pay their creditors. it just so happens that Spectra Science was smart enough to buy their assets (more than likely at a discount, which would be great for everyone, including us).

So lets see, Oncoscope has assests; they developed a proprietary optical imaging system to provide immediate, minimally-invasive detection of pre-cancerous epithelial tissues using scattered white light. But now they need to close shop. Although your first reaction might be to think, "Did they close shop because their technology doesnt work?", that's not typically the case. Nay-sayers will throw this around but let them; they know their time is ending here soon.

When a doughnut shop goes out of business, its not always because their doughnuts tasted awful. In other words, filing for Chapter 7 doesnt have to mean the 'product failed'.

In fact, read this:
Quote:
A business in bankruptcy may be attractive for a variety of reasons. The bankrupt company may possess technology , product lines or services that are complimentary to that of the purchaser. The sale may prove to be a pathway to gain access to a new client base or geographic territory. A bankruptcy purchase may also serve as an effective way to eliminate a competitor.

http://www.brighthub.com/office/entrepreneurs...71428.aspx

Ah, see where this is heading? More questions. It's possible SCIE bought them out as an effective, and cost effective way to eliminate a competitor! Time will tell.

In conclusion, there are many more questions than answers seeing we just heard about this 24 hours ago. We know SCIE is getting Oncoscope's technology because the PR says, 'Having two complementary technologies'.

Questions which remain include:
1. Is the bankruptcy still ongoing or is it completed?
2. Will their facility close down?
3. Will the people of Oncoscope work for Spectra Science?

We know once Chapter 7 is filed, pretty much you have to go through with it, so it appears Oncoscope sold their stuff to SCIE to pay of debt. Good for the company, great for us.
http://www.nolo.com/legal-encyclopedia/can-yo...filed.html

Too many questions to list. What is important for right now is that we know SCIE has once again improved their company by adding this technology to their portfolio. Over the next several weeks, Im sure we'll hear more about the ins and outs of this acquisition.

And then of course, theres the question of what type of acquisition will this be?
http://www.investopedia.com/terms/a/acquisition.asp
http://www.investopedia.com/university/mergers/mergers1.asp

And you know what that means..More PR's.

In all, I'm very excited for this acquisition. I'm sure SCIE got it at a discounted price, and I'm sure this is the next step for SCIE in perfecting the WavSTAT4 for Barrett's esophagus. Good times ahead for us!

Note : Nay-sayers, we're prepared for your one sentence responses backed by no original proof of anything. Of course, any response which includes less than the number of links I provided will be ignored.

SpectraSCIENCE Inc. (SCIE) Stock Research Links

SCIE Board Company Profile Buy Rating Time & Sales News Filings Financials
View My Board Here:
http://investorshangout.com/Joeys-Investment-Board-91611/


Invite Only

There is a VERY HIGH degree of RISK involved in trading and investing. Only invest what you can afford to lose.

Disclaimer:
As used herein, the terms "You" and "Your" shall mean you, individually, the reader, and each other party on whose behalf you may use the contained information at any time.
All references to "My", "I", and “The writer of the above post” shall refer to the creator of the username Joey68.

Do NOT invest unless you are prepared to sustain a total loss of the money you have invested plus any commission or other transaction charges.

There is a very high degree of risk involved in trading and investing. Past results are not indicative of future returns. I assume no responsibility for your trading and investment results. You should NOT rely on the information in the above post to make any decision or take any action.

ALL OF MY STATEMENTS, including but not limited to, POSTS, MESSAGES, PRIVATE MESSAGES, and RESPONSES are OPINION and NOT fact and are for entertainment purposes only. Do your own research and make your own decisions based on your own conclusions.
ALL OF MY STATEMENTS, including but not limited to, POSTS, MESSAGES, PRIVATE MESSAGES, and RESPONSES are NOT advice, and are NOT designed to substitute the expertise and judgment of a professional. It is your responsibility to seek investment advice during all stages of your investments. It is your responsibility to evaluate the accuracy, completeness and usefulness of the information in the above post.
I am NOT a professional.
I do NOT work for you.
My posts are NOT investment advice. I am not paid to post.
There is no correlation between the number of posts I write per day and your assumed success of a company.
It is NOT my responsibility to inform you of my own personal investment decisions.
It is NOT my responsibility to inform you when it is time for you to buy, hold, and/or sell a position.
I have no control over, and am not responsible for the actions of others who copy, store, edit, change, prepare any derivative work of or alter in any way any of the content provided in my posts.
Errors and Omissions expected. The writer of the above post accepts no liability or responsibility for any errors or omissions contained in the above post or contained within this Disclaimer.
The writer of the above post shall NOT accept any liability for the accuracy or completeness of the information contained in the above post, for any reliance placed by any person on the information contained in the above post, or for any damage or loss, however caused, in connection with the use or reliance on any information contained in the above post.
The above post may contain links to websites owned and operated by third parties. These links are provided for informational purposes only and are NOT endorsed by the writer of the above post. The writer of the above post has no control over the contents of any linked website and bears no responsibility for the accuracy, legality, or content of the external site or for that of subsequent links.
YOU ACCESS ALL LINKS ENTIRELY AT YOUR OWN RISK.
The writer of the above post makes no warranties or representations, express or implied about such linked websites, the third parties they are owned and operated by, or the information contained on these websites.
The writer of the above post accepts no liability for any damage or loss, however caused, in connection with the use of or reliance on any information, material, products, or services contained on or accessed through any such linked websites.

There is a VERY HIGH degree of RISK involved in trading and investing. Only invest what you can afford to lose.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 6

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 3

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 4

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 9

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 4

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 5

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 5

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading

Top 5 Most Recently Viewed Articles

Caledon Farms Unveils New Gently Cooked Dog Food Line

Updated Category News Views 264

Caledon Farms Introduces Gently Cooked Dog Food In an exciting move, The Crump Group Inc. is launching a new line of gently cooked dog food under the Caledon Farms brand. This innovative product aims to deliver wholesome and nutritious meals for dogs, featuring high-quality ingredients that pet owners can trust. With its fresh frozen meals, Caledon Farms promises a...

Continue Reading
Air2O's Strategic Partnerships Set to Transform HVAC in 2026

Updated Category News Views 111

Revolutionizing HVAC: The Importance of Partnerships in 2026 As we move closer to a new era in the HVAC industry, industry leaders are beginning to recognize a significant shift in strategy. In the next few years, the focus will not solely lie on advanced technology, but rather on collaborative partnerships. This approach is a response to the growing complexity and...

Continue Reading
ZenaTech Expands Global Presence with New Drone Manufacturing Hub

Updated Category News Views 58

ZenaTech Expands Global Presence with New Drone Manufacturing Hub ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q), a company renowned for its advancements in artificial intelligence drone solutions and enterprise software-as-a-service applications, is making significant strides in its operational footprint. Currently, executives from ZenaTech are participating in a Trade Mission...

Continue Reading
Criteo's Quarterly Performance Drives Strong Results and Growth

Updated Category News Views 155

Overview of Criteo's First Quarter 2025 Financial Results Criteo S.A. (NASDAQ: CRTO), a leading commerce media company, reported robust financial performance for the first quarter of 2025, demonstrating its operational agility and strategic growth initiatives. This quarter, Criteo deployed $56 million towards repurchasing shares, emphasizing its commitment to enhancing...

Continue Reading
Snail Inc. Expands Footprint in Global Short Drama Market

Updated Category News Views 250

Snail Inc. Drives Growth in Short Drama with Recent Recognition Snail, Inc. (Nasdaq: SNAL), a premier developer and publisher within the realm of interactive digital entertainment, has taken a significant step in expanding its global presence through the recent nomination of its Short Drama, Hollywood Heartthrob, for the International Short Drama Awards. This nomination...

Continue Reading